Research Sponsorship Agreements in 2026: Key Clauses and Czech Compliance Risks

The importance of the agreement between the commissioning party and the research institution

The term “commissioning party” refers to a business corporation, entrepreneur, or other institution that requests and finances the research. The research institution, more accurately a research organisation, is typically a public university, a public research institution (v.v.i.), or a private organisation meeting the statutory definitions.

This relationship is not an ordinary purchase of goods, because research by its nature involves elements of uncertainty and no one can guarantee the achievement of a result with 100% certainty. Czech legislation and EU rules for 2026 consistently distinguish between contract research and research collaboration. In practice, this means that if the commissioning party pays a university, the price must be set at market level to avoid so-called indirect state aid to an undertaking.

Many entrepreneurs mistakenly believe that an oral agreement or a brief purchase order is sufficient, and are then surprised by the loss of patent rights or the invalidity of the contract. Concluding these agreements requires expert legal care, as defective drafting may have fatal financial and legal consequences for the commissioning party.

Key elements of the agreement

Defining the subject matter of the research project may at first glance seem trivial; in reality, however, it is the most legally complex part. The agreement must distinguish whether it is a contract for work with an obligation to deliver a result, or an innominate contract with elements of a mandate agreement without a guaranteed result. Research often cannot be planned as precisely as ordinary manufacturing.

The Czech Civil Code and the Act on the Support of Research require the obligation to be sufficiently certain; therefore, the agreement should include:

• Specification of objectives and methodology: A detailed technical description of the investigation, methods used, and output parameters.
• Timeline and milestones: Breaking the project into logical parts with clear deadlines and outputs for each stage.
• Form of outputs: A clear determination of whether the commissioning party will receive a final report, raw data, a physical prototype, or source code.
• Acceptance procedure: The method of confirming acceptance of the output free of defects, which is key for the entitlement to payment to arise.

Without these elements, the obligation is uncertain and, in the event of a dispute, it is very difficult to prove whether the research organisation breached the agreement. The attorneys at ARROWS advokátní kancelář have extensive experience in defining technical appendices and help clients translate technical specifications into enforceable legal language.

Responsible persons and communication

The agreement must clearly determine staffing and authorisations. It is necessary to define the principal investigator who guarantees the professional standard and to set a procedure in case of their departure. It is also necessary to designate the commissioning party’s authorised persons for approving changes and accepting outputs, as well as the method of secure communication.

Financial terms and state aid

The agreement must state the price and its structure, i.e., whether it is a fixed price or time-and-materials billing. Public institutions must calculate the price so that it covers costs and profit; otherwise, there is a risk of unlawful state aid. It is also necessary to set the VAT regime, a payment schedule tied to milestones, and, in the case of grants, to specify eligible costs.

Intellectual property and licensing terms

Under the Czech Copyright Act, rights arise primarily with the author or the research organisation, not automatically with the commissioning party. The agreement must address background intellectual property, where rights remain with the original owner, and the project results, where it is necessary to provide for an assignment of rights or licensing terms.

It is also essential to regulate publication rights so that the commissioning party can exercise a right of veto or defer publication to protect a patent or trade secret. The attorneys at ARROWS can structure licensing arrangements so that the commissioning party obtains the maximum possible control over the results while complying with the statutory limits applicable to the university.

Liability, oversight, and change management

In research, it is problematic to agree on a classic quality guarantee, because functionality at an industrial scale cannot always be guaranteed. The agreement should define liability for conducting the research in accordance with lege artis standards and set a mechanism for notifying defects and remedying them.

Change management

During the research, it may become necessary to change the methodology or objective. The agreement must include a process for proposing a change, approving its impact on the budget, and formalising it by a written amendment. In grant-funded projects, changes are also subject to the grant provider’s approval.

Termination of the agreement

In addition to standard grounds, the agreement should address situations where it is clear that the research objective cannot be achieved. In such a case, it must be clear what portion of the remuneration the institution will receive and who is entitled to the results achieved to date.

Dispute resolution and governing law

The agreement should include a dispute resolution clause, with Czech law as the governing law and the general courts of the Czech Republic having jurisdiction. It should also include a mediation clause with a commitment to attempt an amicable resolution before filing a lawsuit.

The attorneys at ARROWS advokátní kancelář have experience representing clients in these specific disputes and prioritise solutions that preserve the possibility of future cooperation.

Overview of risks and how to address them

Conclusion

A contract between a client and a research organisation is a sophisticated legal instrument involving intangible assets and uncertain outcomes. Underestimating the preparation can lead to loss of monopoly over the results, financial corrections, invalidity of the contract, or costly court disputes.

It is safer to invest in a high-quality contract at the outset. The attorneys at ARROWS, a Prague-based law firm, specialise in research, development, and technology transfer law.

We offer drafting of contract research and collaboration agreements, IP audits, review of contracts submitted by universities, and representation in negotiations. To minimise risks and ensure smooth cooperation, contact ARROWS advokátní kancelář at consultation@arws.cz.

Read also:

• How to Structure Clinical Trials Agreements in Czechia Without Legal Headaches
• Launching a Clinical Trial in the Czech Republic: Key Legal Requirements
• Key Healthcare, Pharma and Food Law Changes in the Czech Republic and EU in 2026
• Procurement of legal services: Basic principles
• How to Choose and Manage External Legal Counsel in Prague Under Czech Law